Old Web
English
Sign In
Acemap
>
authorDetail
>
Martin Glenschek-Sieberth
Martin Glenschek-Sieberth
Bayer HealthCare Pharmaceuticals
Microbiology
Medicine
Ciprofloxacin
Bronchiectasis
Inhalation
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside.
2021
International Journal for Parasitology-Drugs and Drug Resistance
Marc P. Hübner
Simon Townson
Suzanne Gokool
Senyo Tagboto
Mary Maclean
Guilherme G. Verocai
Adrian J. Wolstenholme
Stefan J. Frohberger
Achim Hoerauf
Sabine Specht
Ivan Scandale
Achim Harder
Martin Glenschek-Sieberth
Steffen Hahnel
Daniel Kulke
Show All
Source
Cite
Save
Citations (0)
Efficacy of ciprofloxacin against resistant mucoid or non-mucoid P. aeruginosa isolated from non-cystic fibrosis bronchiectasis (NCFB) patients considering lung pharmacokinetics after ciprofloxacin DPI treatment
2014
European Respiratory Journal
Sabine Obertegger
Gabriele Weskott
Petra Surdakowski
Martin Glenschek-Sieberth
Show All
Source
Cite
Save
Citations (0)
Bactericidal activity of ciprofloxacin dry powder for inhalation (DPI) in a hollow fiber (HF) model
2014
European Respiratory Journal
Sabine Obertegger
Gabriele Weskott
Petra Surdakowski
Karina Merfort
Martin Glenschek-Sieberth
Show All
Source
Cite
Save
Citations (0)
Effectiveness of quinolone monotherapy versus combination therapy in difficult to treat mixed infections with Escherichia coli and Bacteroides fragilis.
2009
Infection
Martin Glenschek-Sieberth
K. Merfort
Sabine Obertegger
R. Endermann
Show All
Source
Cite
Save
Citations (0)
In vivo efficacy of human therapeutic doses of moxifloxacin and piperacillin\tazobactam in an animal model of complicated intra-abdominal infections.
2009
Infection
R. Endermann
D. Hoepker
K. Merfort
Martin Glenschek-Sieberth
Show All
Source
Cite
Save
Citations (0)
1